Commerce Bank’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,087
Closed -$759K 1168
2022
Q3
$759K Buy
3,087
+808
+35% +$218K 0.01% 620
2022
Q2
$564K Sell
2,279
-11,227
-83% -$3.03M ﹤0.01% 741
2022
Q1
$4.47M Sell
13,506
-376
-3% -$116K 0.03% 327
2021
Q4
$4.99M Sell
13,882
-834
-6% -$282K 0.03% 316
2021
Q3
$4.79M Sell
14,716
-1,341
-8% -$454K 0.03% 326
2021
Q2
$5.01M Sell
16,057
-319
-2% -$97.9K 0.04% 321
2021
Q1
$5.22M Buy
16,376
+14,447
+749% +$4.62M 0.04% 302
2020
Q4
$626K Sell
1,929
-60
-3% -$16.6K 0.01% 699
2020
Q3
$551K Sell
1,989
-143
-7% -$41.2K 0.01% 660
2020
Q2
$515K Sell
2,132
-200
-9% -$40.2K 0.01% 656
2020
Q1
$338K Buy
2,332
+514
+28% +$85.3K ﹤0.01% 715
2019
Q4
$310K Buy
1,818
+161
+10% +$29.8K ﹤0.01% 813
2019
Q3
$295K Buy
1,657
+387
+30% +$83.7K ﹤0.01% 782
2019
Q2
$330K Buy
+1,270
New +$337K ﹤0.01% 740
2018
Q4
Sell
-726
Closed -$327K 901
2018
Q3
$327K Sell
726
-434
-37% -$171K ﹤0.01% 712
2018
Q2
$474K Sell
1,160
-5,675
-83% -$2.06M 0.01% 586
2018
Q1
$1.99M Buy
6,835
+1,785
+35% +$452K 0.03% 296
2017
Q4
$947K Buy
+5,050
New +$943K 0.01% 413

Other funds holding ABMD

Commerce Bank's ABMD Position: Q4 2022 in Review

Commerce Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,087 shares — an estimated $759K sold.

Commerce Bank first reported a position in ABMD in Q4 2017 and held it in 18 quarters. The position peaked at $5.22M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Commerce Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Commerce Bank sold 3,087 Abiomed Inc shares in Q4 2022, an estimated $759K.
  • Commerce Bank first reported a position in Abiomed Inc in Q4 2017 and held it in 18 quarters.
  • Commerce Bank's Abiomed Inc position peaked at $5.22M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Commerce Bank's 13F filing for Q4 2022, filed 10 Feb 2023.